Kymera Therapeutics KYMR Holds Steady Near 80 as Key Levels Come into Focus PDF Solutions PDFS Q1 2026 Earnings 031 EPS Surges Past 024 Estimates Musk Slams Altman Trial Verdict as a Technicality Vows to Appeal Cats Find Silver Vine More Potent Than Catnip Japan Study Points to New Pet Product Opportunities